These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 33184753)

  • 1. Development and evaluation of a serological test for diagnosis of COVID-19 with selected recombinant spike proteins.
    Zhang P; Gao Q; Wang T; Ke Y; Mo F; Jia R; Liu W; Liu L; Zheng S; Liu Y; Li L; Wang Y; Xu L; Hao K; Min W; Liu X; Yang R; Li S; Lin C; Zhao Y
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):921-928. PubMed ID: 33184753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
    De Marco Verissimo C; O'Brien C; López Corrales J; Dorey A; Cwiklinski K; Lalor R; Doyle JM; Field S; Masterson C; Ribes Martinez E; Hughes G; Bergin C; Walshe K; McNicholas B; Laffey JG; Dalton JP; Kerr C; Doyle S
    Epidemiol Infect; 2021 Jun; 149():e140. PubMed ID: 34099081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of highly specific monoclonal antibodies against SARS-CoV-2 nucleocapsid protein and the preliminary development of antigen detection test strips.
    Xie C; Ding H; Ding J; Xue Y; Lu S; Lv H
    J Med Virol; 2022 Apr; 94(4):1633-1640. PubMed ID: 34904253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19.
    Flinck H; Rauhio A; Luukinen B; Lehtimäki T; Haapala AM; Seiskari T; Aittoniemi J
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115197. PubMed ID: 32977117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a quantitative COVID-19 multiplex assay and its use for serological surveillance in a low SARS-CoV-2 incidence community.
    Guarino C; Larson E; Babasyan S; Rollins A; Joshi LR; Laverack M; Parrilla L; Plocharczyk E; Diel DG; Wagner B
    PLoS One; 2022; 17(1):e0262868. PubMed ID: 35061843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complexities of SARS-CoV-2 serology.
    Houlihan CF; Beale R
    Lancet Infect Dis; 2020 Dec; 20(12):1350-1351. PubMed ID: 32979317
    [No Abstract]   [Full Text] [Related]  

  • 7. A Multiplex Microsphere IgG Assay for SARS-CoV-2 Using ACE2-Mediated Inhibition as a Surrogate for Neutralization.
    Cameron A; Porterfield CA; Byron LD; Wang J; Pearson Z; Bohrhunter JL; Cardillo AB; Ryan-Muntz L; Sorensen RA; Caserta MT; Angeloni S; Hardy DJ; Zand MS; Pecora ND
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2.
    Rusanen J; Kareinen L; Levanov L; Mero S; Pakkanen SH; Kantele A; Amanat F; Krammer F; Hedman K; Vapalahti O; Hepojoki J
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics.
    Jalkanen P; Pasternack A; Maljanen S; Melén K; Kolehmainen P; Huttunen M; Lundberg R; Tripathi L; Khan H; Ritvos MA; Naves R; Haveri A; Österlund P; Kuivanen S; Jääskeläinen AJ; Kurkela S; Lappalainen M; Rantasärkkä K; Vuorinen T; Hytönen J; Waris M; Tauriainen S; Ritvos O; Kakkola L; Julkunen I
    J Infect Dis; 2021 Jul; 224(2):218-228. PubMed ID: 33905505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2.
    Djukic T; Mladenovic M; Stanic-Vucinic D; Radosavljevic J; Smiljanic K; Sabljic L; Devic M; Cujic D; Vasovic T; Simovic A; Radomirovic M; Cirkovic Velickovic T
    Virology; 2021 May; 557():15-22. PubMed ID: 33582454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
    Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
    Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Back to normal; serological testing for COVID-19 diagnosis unveils missed infections.
    Tsuchida T; Nitahara Y; Suzuki S; Komase Y; Candray K; Kido Y; Nakagama Y; Yamasaki Y; Imamura M; Kawahata K; Kunishima H; Fujitani S; Mineshita M; Matsuda T
    J Med Virol; 2021 Jul; 93(7):4549-4552. PubMed ID: 33739483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array.
    Fisher M; Levy H; Fatelevich E; Afrimov Y; Ben-Shmuel A; Rosenfeld R; Noy-Porat T; Glinert I; Sittner A; Biber A; Belkin A; Bar-David E; Puni R; Levy I; Mazor O; Weiss S; Mechaly A
    Microbiol Spectr; 2021 Oct; 9(2):e0087021. PubMed ID: 34612689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large scale production and characterization of SARS-CoV-2 whole antigen for serological test development.
    Cerutti H; Ricci V; Tesi G; Soldatini C; Castria M; Vaccaro MN; Tornesi S; Toppi S; Verdiani S; Brogi A
    J Clin Lab Anal; 2021 Apr; 35(4):e23735. PubMed ID: 33608968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of antigens expressed in Nicotiana benthamiana plant and Escherichia coli for the SARS-CoV-2 IgG antibody detection by ELISA.
    Fogaça MBT; Lopes-Luz L; Saavedra DP; de Oliveira NKAB; Jesus Sousa MB; Perez JDP; de Andrade IA; Crispim GJB; Pinto LDS; Ferreira MRA; Ribeiro BM; Nagata T; Conceição FR; Stefani MMA; Bührer-Sékula S
    J Virol Methods; 2024 Sep; 329():114969. PubMed ID: 38834144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection-SARS-CoV-2 as a Proof of Concept.
    Rusanen J; Kareinen L; Szirovicza L; Uğurlu H; Levanov L; Jääskeläinen A; Ahava M; Kurkela S; Saksela K; Hedman K; Vapalahti O; Hepojoki J
    mBio; 2021 May; 12(3):. PubMed ID: 34006662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Integrated Platform for Serological Detection and Vaccination of COVID-19.
    Wei SC; Hsu WT; Chiu CH; Chang FY; Lo HR; Liao CY; Yang HI; Chou YC; Tsai CH; Chao YC
    Front Immunol; 2021; 12():771011. PubMed ID: 35003088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.